ResMed Inc.
RMD
Classifica tra le azioni
#726
ResMed Inc. is a leading global medical technology enterprise engaged in the... ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
Prezzo delle azioni
$238.47
Ultima sincronizzazione: 2026-10-16
Capitalizzazione di mercato
$33.54B
Variazione (1 giorno)
-1.59%
Variazione (1 anno)
-11.05%
Paese
US
Scambia ResMed Inc. (RMD)
Categoria
Healthcare
Margine operativo per ResMed Inc. (RMD)
Margine operativo al October 2026 TTM: 33.48%
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di ResMed Inc., il margine operativo attuale (TTM) è 33.48%. Alla fine del 2024, il margine operativo era 28.17%.
Storico del margine operativo per ResMed Inc. da 2000 a 2026
Margine operativo alla fine di ogni anno
| Anno | Margine Operativo | Cambia |
|---|---|---|
| 2026 (TTM) | 33.48% | 2.23% |
| 2025 | 32.75% | 16.26% |
| 2024 | 28.17% | 5.11% |
| 2023 | 26.80% | -4.15% |
| 2022 | 27.96% | -1.10% |
| 2021 | 28.27% | 3.25% |
| 2020 | 27.38% | 23.22% |
| 2019 | 22.22% | -4.02% |
| 2018 | 23.15% | 12.38% |
| 2017 | 20.60% | -11.70% |
| 2016 | 23.33% | -4.31% |
| 2015 | 24.38% | -6.41% |
| 2014 | 26.05% | 11.18% |
| 2013 | 23.43% | 8.93% |
| 2012 | 21.51% | 0.19% |
| 2011 | 21.47% | -2.45% |
| 2010 | 22.01% | 6.48% |
| 2009 | 20.67% | 20.81% |
| 2008 | 17.11% | 35.90% |
| 2007 | 12.59% | -41.79% |
| 2006 | 21.63% | -5.46% |
| 2005 | 22.88% | -9.06% |
| 2004 | 25.16% | 2.36% |
| 2003 | 24.58% | -198.05% |
| 2002 | -25.07% | -249.40% |
| 2001 | 16.78% | -41.45% |
| 2000 | 28.66% | 0.00% |
Margine operativo per aziende simili o concorrenti
| Azienda | Margine Operativo | Differenza del margine operativo | Il paese |
|---|---|---|---|
| 17.03% | -99.49% |
US
|
|
| 17.86% | -99.47% |
IE
|
|
| 22.03% | -99.34% |
US
|
|
| 21.46% | -99.36% |
US
|
|
| 0.00% | - |
DE
|
Cos'è l'Margine operativo di un'azienda?
L'Margine operativo è un indicatore chiave per valutare la redditività di un'azienda. Margini operativi più elevati sono generalmente preferibili poiché indicano che l'azienda riesce a vendere i propri prodotti o servizi a un prezzo significativamente superiore rispetto ai costi di produzione. Si calcola dividendo gli utili per i ricavi.